Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review
The management of advanced gastric cancer has improved over the past decade. There is more evidence to support the efficacy of systemic treatment in refractory gastric cancer beyond second-line treatment. Important randomized controlled trials of chemotherapies, targeted agents and immunotherapies h...
Main Authors: | Wing-lok Chan, Ka-on Lam, Tsz-him So, Victor Ho-fun Lee, Lai-wan Dora Kwong |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-06-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835919859990 |
Similar Items
-
Local and systemic treatment for HER2-positive breast cancer with brain metastases: a comprehensive review
by: Wing-Lok Chan, et al.
Published: (2020-09-01) -
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
by: Sik-Kwan Chan, et al.
Published: (2020-08-01) -
The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
by: Horace Cheuk-Wai Choi, et al.
Published: (2021-02-01) -
Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis
by: Wen-Tao Pan, et al.
Published: (2020-04-01) -
Advances in systemic treatment of metastatic gastric cancer
by: Popov Ivan, et al.
Published: (2003-01-01)